Know Cancer

or
forgot password


N/A
18 Years
N/A
Not Enrolling
Both
Naevi, Malignant Melanoma

Thank you

Trial Information


Inclusion Criteria:



- Patients with benign melanocytic naevi, dysplastic melanocytic naevi and cutaneous
malignant melanoma.

Exclusion Criteria:

- Patients under 18 years of age

- Patients with other forms of cancer in previous medical history

- Pregnancy

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Principal Investigator

Prof. Dr. Peter Altmeyer

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Dermatology and Allergology, Ruhr-University Bochum

Authority:

Germany: Ethics Commission

Study ID:

006

NCT ID:

NCT00862914

Start Date:

July 2008

Completion Date:

March 2009

Related Keywords:

  • Naevi
  • Malignant Melanoma
  • Skin
  • MicroRNA
  • miRNA
  • Dicer
  • Malignant Melanoma
  • Melanoma
  • Nevus
  • Nevus, Pigmented

Name

Location